<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2022.749476</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Trypanosoma cruzi</italic> Mitochondrial Peroxiredoxin Promotes Infectivity in Macrophages and Attenuates Nifurtimox Toxicity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Specker</surname>
<given-names>Gabriela</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1504935"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Estrada</surname>
<given-names>Dami&#xe1;n</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Radi</surname>
<given-names>Rafael</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Piacenza</surname>
<given-names>Luc&#xed;a</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1030624"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Departamento de Bioqu&#xed;mica and Centro de Investigaciones Biom&#xe9;dicas (CEINBIO), Facultad de Medicina, Universidad de la Rep&#xfa;blica</institution>, <addr-line>Montevideo</addr-line>, <country>Uruguay</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Tania F. De Koning-Ward, Deakin University, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Fred David Mast, Seattle Children&#x2019;s Research Institute, United States; Alexis Kaushansky, University of Washington, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Luc&#xed;a Piacenza, <email xlink:href="mailto:lpiacenza@fmed.edu.uy">lpiacenza@fmed.edu.uy</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>12</volume>
<elocation-id>749476</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>07</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Specker, Estrada, Radi and Piacenza</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Specker, Estrada, Radi and Piacenza</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<italic>Trypanosoma cruzi</italic> is the causative agent of Chagas disease which is currently treated by nifurtimox (NFX) and benznidazole (BZ). Nevertheless, the mechanism of action of NFX is not completely established. Herein, we show the protective effects of <italic>T. cruzi</italic> mitochondrial peroxiredoxin (MPX) in macrophage infections and in response to NFX toxicity. After a 3-day treatment of epimastigotes with NFX, MPX content increased (2.5-fold) with respect to control, and interestingly, an MPX-overexpressing strain was more resistant to the drug. The generation of mitochondrial reactive species and the redox status of the low molecular weight thiols of the parasite were not affected by NFX treatment indicating the absence of oxidative stress in this condition. Since MPX was shown to be protective and overexpressed in drug-challenged parasites, non-classical peroxiredoxin activity was studied. We found that recombinant MPX exhibits holdase activity independently of its redox state and that its overexpression was also observed in temperature-challenged parasites. Moreover, increased holdase activity (2-fold) together with an augmented protease activity (proteasome-related) and an enhancement in ubiquitinylated proteins was found in NFX-treated parasites. These results suggest a protective role of MPX holdase activity toward NFX toxicity. <italic>Trypanosoma cruzi</italic> has a complex life cycle, part of which involves the invasion of mammalian cells, where parasite replication inside the host occurs. In the early stages of the infection, macrophages recognize and engulf <italic>T. cruzi</italic> with the generation of reactive oxygen and nitrogen species toward the internalized parasite. Parasites overexpressing MPX produced higher macrophage infection yield compared with wild-type parasites. The relevance of peroxidase vs. holdase activity of MPX during macrophage infections was assessed using conoidin A (CA), a covalent, cell-permeable inhibitor of peroxiredoxin peroxidase activity. Covalent adducts of MPX were detected in CA-treated parasites, which proves its action <italic>in vivo</italic>. The pretreatment of parasites with CA led to a reduced infection index in macrophages revealing that the peroxidase activity of peroxiredoxin is crucial during this infection process. Our results confirm the importance of peroxidase activity during macrophage infection and provide insights for the relevance of MPX holdase activity in NFX resistance.</p>
</abstract>
<kwd-group>
<kwd>
<italic>T. cruzi</italic>
</kwd>
<kwd>nifurtimox</kwd>
<kwd>mitochondrial peroxiredoxin</kwd>
<kwd>macrophage infection</kwd>
<kwd>holdase and peroxidase activities</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="76"/>
<page-count count="15"/>
<word-count count="9642"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>
<italic>Trypanosoma cruzi</italic> (<italic>T. cruzi</italic>) is the intracellular parasite that causes Chagas disease, which is considered a neglected disease and remains a public health problem in Latin America, estimated to affect approximately 6 million people and with 70 million at risk of infection (<xref ref-type="bibr" rid="B39">P&#xe9;rez-Molina and Molina, 2018</xref>). <italic>Trypanosoma cruzi</italic> has a complex life cycle that involves two hosts, the insect vector and the vertebrate host, and four stages of the parasite. The replicative, non-infective epimastigote stage is found in the insect midgut and, during its migration to the hindgut, differentiates to the infective, non-replicative metacyclic trypomastigotes that can invade different vertebrate cells. Inside cells, trypomastigote transforms into the infective, replicative intracellular amastigote. Following several rounds of replication, the infective blood trypomastigote escapes and disseminates the infection to other tissues. During the life cycle, parasite survival depends on its rapid and efficient adaptation to the distinct environments faced, which is accomplished by extensive biochemical and morphological changes. <italic>Trypanosoma cruzi</italic> is a heterogeneous species, with large genetic variability and different strains that circulate between the vertebrate host and the insect vector. This heterogeneity may explain the variation in the clinical manifestation of Chagas disease and the geographical differences in morbidity and mortality (<xref ref-type="bibr" rid="B24">Laurent et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B26">Da Silva Manoel-Caetano and Silva, 2007</xref>; <xref ref-type="bibr" rid="B33">McCall and McKerrow, 2014</xref>).</p>
<p>Activation of professional phagocytes (macrophages and neutrophils) with the concomitant generation of oxidant species is a medullar innate immune process for the control of acute <italic>T. cruzi</italic> infection. Recent data reinforce the hypothesis that parasites more prepared to deal with the host-oxidative assault are more efficient for the establishment of the infection (<xref ref-type="bibr" rid="B42">Piacenza et&#xa0;al., 2009a</xref>; <xref ref-type="bibr" rid="B1">Alvarez et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B28">Martinez et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B10">Estrada et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B48">Piacenza et&#xa0;al., 2019</xref>). Nevertheless, <italic>T. cruzi</italic> contains a complex system of antioxidant enzymes and related proteins that allows it to overcome the oxidants, produced by the host immune response (<xref ref-type="bibr" rid="B73">Wilkinson et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B30">Mateo et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B42">Piacenza et&#xa0;al., 2009b</xref>; <xref ref-type="bibr" rid="B69">Wilkinson et al., 2002a</xref>; <xref ref-type="bibr" rid="B70">Wilkinson et al., 2002b</xref>; <xref ref-type="bibr" rid="B72">Wilkinson et al., 2002c</xref>). This antioxidant system has multiple components distributed in all parasite subcellular compartments, where they maintain the redox balance playing a key role in parasite virulence and persistence in tissues (<xref ref-type="bibr" rid="B46">Piacenza et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B10">Estrada et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B48">Piacenza et&#xa0;al., 2019</xref>).</p>
<p>Peroxide metabolism in <italic>T. cruzi</italic> relies on five peroxidases located in different subcellular compartments: heme-containing cytochrome c ascorbate peroxidase, two glutathione-like peroxidases and two peroxiredoxins, ubiquitous peroxidases that depend on cysteine residues to reduce peroxides (<xref ref-type="bibr" rid="B73">Wilkinson et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B69">Wilkinson et&#xa0;al., 2002a</xref>; <xref ref-type="bibr" rid="B70">Wilkinson et&#xa0;al., 2002b</xref>; <xref ref-type="bibr" rid="B72">Wilkinson et&#xa0;al., 2002c</xref>; <xref ref-type="bibr" rid="B17">Hugo et&#xa0;al., 2017</xref>). Both the cytosolic (CPX) and the mitochondrial peroxiredoxin (MPX) are two cysteine-typical peroxiredoxins which use tryparedoxin (TXN) as reducing substrate. The oxidized TXN is then reduced by trypanothione [T(SH)<sub>2</sub>], a low molecular weight thiol unique to trypanosomatids, at the expense of NADPH. <italic>Trypanosoma cruzi</italic> peroxiredoxins are able to detoxify H<sub>2</sub>O<sub>2</sub>, peroxynitrite (ONOOH), and short-chain organic hydroperoxides (ROOH), and its level of expression has been correlated with the virulence of different strains (<xref ref-type="bibr" rid="B73">Wilkinson et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B67">Trujillo et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B51">Pi&#xf1;eyro et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B42">Piacenza et&#xa0;al., 2009b</xref>). In most two cys-typical peroxiredoxins, such as MPX and CPX, the basic functional unit is the dimer, but generally, they are able to establish higher-order structures specifically as octameric, decameric, and dodecameric toroids (<xref ref-type="bibr" rid="B5">Cao and Lindsay, 2017</xref>). In recent years, it has been described in many organisms that peroxiredoxins, besides its function as peroxidases, have other activities such as holdase and as part of signaling pathways (<xref ref-type="bibr" rid="B57">Rhee et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B41">Perkins et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B61">Sobotta et&#xa0;al., 2015</xref>). Holdases are part of the molecular chaperone family which prevents aggregation of proteins in an ATP-independent manner (<xref ref-type="bibr" rid="B11">Folgueira and Requena, 2007</xref>; <xref ref-type="bibr" rid="B22">Kim et&#xa0;al., 2013</xref>). Holdase activity is crucial for cellular protection during different stress conditions that induces protein damage and unfolding with the possible formation of protein aggregates. The interplay between the peroxidase and holdase function of peroxiredoxins is regulated by several environments in the cell such as pH, temperature, ions, posttranslational modifications, and redox balance (<xref ref-type="bibr" rid="B20">Jang et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B58">Saccoccia et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B36">Morais et&#xa0;al., 2017a</xref>). Moreover, holdase activity seems to be related to the oligomeric state of the enzyme, taking into consideration that holdase activity is mainly reported in decameric or higher molecular weight oligomers, which means that conditions that favor the said structure will stimulate this activity in peroxiredoxins. It is proposed that oligomerization dynamics and, therefore, holdase function are dependent on the redox state of the cell, given that oxidized forms of peroxiredoxins, which have mainly dimeric conformations, do not exhibit holdase activity, whereas their reduced or overoxidized forms, which form decamers and/or higher molecular weight oligomers, display holdase activity (<xref ref-type="bibr" rid="B74">Wood et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B75">Wood et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B56">Rhee and Woo, 2011</xref>; <xref ref-type="bibr" rid="B41">Perkins et&#xa0;al., 2015</xref>). However, there are reports that also show that oxidized peroxiredoxins are able to acquire high molecular weight conformations, and thus, the precise relationship between redox state and holdase activity will depend on the specific peroxiredoxin under study (<xref ref-type="bibr" rid="B76">Yewdall et&#xa0;al., 2016</xref>). Regarding these novel functions, it was found that <italic>T. cruzi</italic> CPX has the ability to prevent aggregation of malate dehydrogenase <italic>in vitro</italic> independently of its redox state (<xref ref-type="bibr" rid="B50">Pi&#xf1;eyro et&#xa0;al., 2019</xref>). Furthermore, the crystal structure of the CPX is available and shows that it is a toroid-shaped decamer in its active and reduced form (<xref ref-type="bibr" rid="B52">Pi&#xf1;eyro et&#xa0;al., 2005</xref>), like most peroxiredoxins that act as holdases. It was shown that this peroxiredoxin does not disassemble into dimers upon oxidation. Nonetheless, it has not been yet proven <italic>in vivo</italic> that <italic>T. cruzi</italic> peroxiredoxins have holdase activity. In <italic>Leishmania infantum</italic>, another trypanosomatid with long-lasting residence in the macrophage phagosome, it has been reported that mitochondrial peroxiredoxin (<italic>Li</italic>Prx1m) presents holdase activity <italic>in vitro</italic> and that a deficiency in this enzyme yields parasites more sensitive to a rise in temperature (<xref ref-type="bibr" rid="B6">Castro et&#xa0;al., 2011</xref>). These deficient parasites also presented a decreased survival in macrophages, but interestingly, they could be rescued by the expression of the <italic>Li</italic>Prx1m in which the peroxidatic cysteine (Cp) was absent, indicating that other activity than the classical peroxidase (i.e., holdase) is involved in protecting amastigotes to macrophage-derived stressors (<xref ref-type="bibr" rid="B6">Castro et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B63">Teixeira et&#xa0;al., 2015</xref>).</p>
<p>Treatment of Chagas disease relies mainly on two old and poorly specific chemotherapeutic agents: benznidazole (BZ) and nifurtimox (NFX). These drugs have several disadvantages; they are only effective in the acute phase of the disease, treatment may last for months with important side effects, and there are resistant strains (<xref ref-type="bibr" rid="B55">Rassi et&#xa0;al., 2010</xref>). Both of these drugs are nitroheterocycle compounds: NFX is a nitrofurane derivative, while BZ is a nitroimidazole. The mode of action of NFX is still elusive and two major mechanisms have been proposed, which agree in the fact that NFX has to be metabolized to act as an anti-trypanosomatid drug. First, NFX toxicity was explained by NFX redox cycling with superoxide radical (O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup>) and H<sub>2</sub>O<sub>2</sub> production (<xref ref-type="bibr" rid="B9">Docampo and Stoppani, 1979</xref>; <xref ref-type="bibr" rid="B8">Docampo and Moreno, 1984</xref>), with a concomitant increase in oxidative stress within the parasite. The drug was thought to be activated by one electron reduction catalyzed by type II nitroreductase (NTR-II), producing nitrofurane radical, that in aerobic conditions gives rise to a futile cycle that results in regeneration of the nitro group and production of O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup> which dismutate to H<sub>2</sub>O<sub>2</sub> and O<sub>2</sub> catalyzed by superoxide dismutases (SODs) in a diffusion-controlled reaction (<xref ref-type="bibr" rid="B34">McCord and Fridovich, 1969</xref>). This postulation is based on the observation that after NFX treatment, parasite extracts showed an increased oxygen consumption and production of O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup> as well as in the fact that <italic>Trypanosoma brucei</italic> strains deficient in cytosolic iron SOD (TbSODB1) showed more sensitivity toward NFX (Roberto <xref ref-type="bibr" rid="B9">Docampo and Stoppani, 1979</xref>; <xref ref-type="bibr" rid="B53">Prathalingham Radhika et&#xa0;al., 2007</xref>). Moreover, it was reported that treatment with NFX leads to depletion of the principal low molecular weight thiols of the parasite, although it was discussed that this could be explained by redox cycling of the drug or by conjugation of thiols with drug metabolites (<xref ref-type="bibr" rid="B31">Maya et&#xa0;al., 1997</xref>).</p>
<p>The second mechanism relies on the activation of NFX by a parasite NADH-dependent mitochondrial type I nitroreductase (NTR-I), insensitive to O<sub>2</sub>, that has FMN as cofactor and catalyzes sequential 2-electron reduction steps to yield unsaturated open chain nitriles that have trypanocidal activities with no significant generation of oxidative stress (<xref ref-type="bibr" rid="B2">Boiani et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B14">Hall et&#xa0;al., 2011</xref>). <italic>Trypanosoma cruzi-</italic>resistant strains have only one copy of <italic>Tc</italic>NTR-I gene, and genetic modification of parasites to give knockout or overexpressers resulted in resistant or hypersensitive parasites to NFX, respectively. This shows a connection between NTR-I activity and nifurtimox toxicity (<xref ref-type="bibr" rid="B71">Wilkinson et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B7">Cerecetto and Gonz&#xe1;lez, 2011</xref>).</p>
<p>Taking into consideration the abovementioned results related to the peroxiredoxins of trypanosomatids and its different functions within the cell, we evaluated the ability of <italic>T. cruzi</italic> mitochondrial peroxiredoxin to act as holdase and studied the relative weight of both activities (peroxidase and holdase) toward macrophage and NFX-derived toxicity. The results presented herein contribute to the understanding of the role of <italic>T. cruzi</italic> mitochondrial peroxiredoxin in response to different stress, gaining insights into the redox and holdase function of this peroxidase.</p>
</sec>
<sec id="s2" sec-type="results">
<title>Results</title>
<sec id="s2_1">
<title>Parasites Overexpressing MPX Are More Resistant to NFX Toxicity</title>
<p>In order to evaluate the influence of MPX content in parasites on NFX toxicity, the growth curves of epimastigotes in the absence or presence of the drug in a concentration close to its IC<sub>50</sub> (7&#xa0;&#x3bc;M) were performed (<xref ref-type="bibr" rid="B2">Boiani et&#xa0;al., 2010</xref>). WT and genetically transformed parasites to overexpress MPX (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>) (<xref ref-type="bibr" rid="B45">Piacenza et&#xa0;al., 2008</xref>) showed a similar growth profile in control conditions (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>), whereas in the presence of NFX, MPX-overexpressing parasites showed an increased resistance to the toxic effects of the drug compared with WT parasites (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>, upper and lower panels). Since MPX is able to detoxify different peroxides and taking into account that this species may be generated during the early stages of NFX metabolism in some circumstances, we searched for the generation of reactive oxygen species following dihydrorhodamine (DHR) oxidation. Parasites treated for 2&#xa0;h with the drug were loaded with DHR and the formation of RH123, the oxidized product, was evaluated. No increase in probe oxidation was observed in our experimental conditions (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Parasite treatment with H<sub>2</sub>O<sub>2</sub> (300&#xa0;&#xb5;M) for 30&#xa0;min was previously shown to increase intramitochondrial superoxide radical generation (<xref ref-type="bibr" rid="B10">Estrada et&#xa0;al., 2018</xref>) and was used herein as a positive control. Increased DHR oxidation was observed in H<sub>2</sub>O<sub>2</sub>-treated parasites, and this was significantly enhanced when parasites were previously (24&#xa0;h) incubated in the presence of buthionine-S,R-sulfoximine (BSO), an inhibitor of GSH synthesis (<xref ref-type="bibr" rid="B13">Griffith and Meister, 1979</xref>; <xref ref-type="bibr" rid="B35">Meister, 1995</xref>). In this condition, overexpression of MPX leads to a significantly lower DHR oxidation with respect to WT parasites (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). The levels of non-protein thiols [i.e., GSH and T(SH)<sub>2</sub>] were evaluated daily during the growth curve in non-treated and NFX-treated parasites by mBrBm derivatization and HPLC-fluorescent detection (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). GSH (0.6&#xa0;&#xb1;&#xa0;0.2&#xa0;nmol/10<sup>8</sup> cells) and T(SH)<sub>2</sub> (1.6&#xa0;&#xb1;&#xa0;0.6&#xa0;nmol/10<sup>8</sup> cells) remain unchanged during the 5-day incubation with NFX with intracellular levels in the order of that previously reported (<xref ref-type="bibr" rid="B65">Thomson et&#xa0;al., 2003</xref>). Overall, our results suggest that in our experimental conditions, NFX is not generating a redox cycle with the production of reactive oxygen species, and thus, the protective effects observed in MPX-overexpressing parasites seem not to be ascribable to its peroxidase activity. Moreover, since it was proposed that NFX is activated at the parasite mitochondria, we examined the mitochondrial membrane potential after a 3-day parasite culture with the drug by rhodamine-123 incorporation and the site-specific generation of O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup>/H<sub>2</sub>O<sub>2</sub> by MitoSOX oxidation (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). NFX treatment of WT parasites caused a significant decrease (30%) of mitochondrial membrane potential with respect to non-treated parasites, whereas no changes in mitochondrial membrane potential were observed for MPX-overexpressing parasites (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). FCCP, a mitochondrial uncoupler, was used as a positive control of mitochondrial depolarization. Finally, MitoSOX oxidation was evaluated in parasites following a 2-h incubation with NFX, and also, non-detectable oxidation of the probe was observed in drug-treated parasites. Parasite treatment with H<sub>2</sub>O<sub>2</sub> as described above (300&#xa0;&#xb5;M, 30&#xa0;min) was used as a positive control (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>), given that this treatment leads to mitochondrial superoxide radical generation (<xref ref-type="bibr" rid="B10">Estrada et&#xa0;al., 2018</xref>). The results presented herein suggest that enhanced content of MPX protects parasites for the NFX toxicity at the mitochondrial compartment.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The protective role of mitochondrial peroxiredoxin (MPX) toward nifurtimox (NFX) in epimastigotes without modifying redox state. <bold>(A)</bold> Growth curve of epimastigotes wild type (WT) (upper panel) and MPX-overexpressing parasites (lower panel) in the absence or presence of NFX (7&#xa0;&#x3bc;M). Parasites were cultured in BHI medium at 28&#xb0;C and cell density was evaluated every day by absorbance at 600&#xa0;nm. * denotes statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.05) and ** statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.01) compared with non-treated (two-tailed unpaired <italic>t</italic>-test). <bold>(B)</bold> Dihydrorhodamine (DHR) oxidation. Non-treated or overnight BSO-treated parasites were preloaded with DHR (50&#xa0;&#x3bc;M) and exposed either to NFX (7&#xa0;&#x3bc;M, 2&#xa0;h) or H<sub>2</sub>O<sub>2</sub> (300&#xa0;&#x3bc;M, 30&#xa0;min). DHR oxidation was measured in a fluorescence plate reader (Varioskan Flash, Thermo Scientific) at <italic>&#x3bb;</italic>
<sub>ex</sub>&#xa0;=&#xa0;485&#xa0;nm and <italic>&#x3bb;</italic>
<sub>em</sub>&#xa0;=&#xa0;520&#xa0;nm. Upper panel: DHR oxidation in WT parasites. Lower panel: DHR oxidation in parasites overexpressing MPX. Results are expressed as fluorescence units with respect to non-treated WT condition. ** denotes statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.01) compared with non-treated condition (two-tailed unpaired <italic>t</italic>-test). <bold>(C)</bold> The content of reduced low molecular weight (LMW) thiols in WT epimastigotes (1&#xa0;&#xd7;&#xa0;10<sup>8</sup> cells) incubated for different times with NFX (7&#xa0;&#x3bc;M) was determined by HPLC as described. Upper panel: Quantification of GSH in non-treated (white bars) and NFX-treated WT parasites (black bars) at different times. Lower panel: Quantification of T(SH)<sub>2</sub> in non-treated (white bars) and NFX-treated WT parasites (black bars). Results are expressed as nmol thiol/10<sup>8</sup> parasites.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-749476-g001.tif"/>
</fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Overexpression of MPX prevents loss of mitochondrial membrane potential in epimastigotes treated with NFX. <bold>(A)</bold> Evaluation of the mitochondrial membrane potential of epimastigotes WT and MPX overexpressers without treatment (left histogram) or treated with NFX (7&#xa0;&#x3bc;M, 2&#xa0;h, right histogram) performed with the mitochondrial probe RH123 by flow cytometry. FCCP was used as a control of mitochondrial depolarization (left panel). <bold>(B)</bold> Parasite mitochondrial O<sub>2</sub>
<sup>&#x2022;&#x2212;</sup>/H<sub>2</sub>O<sub>2</sub> generation was evaluated by MitoSOX oxidation and analyzed by flow cytometry. Following NFX treatment (7&#xa0;&#x3bc;M, 2&#xa0;h) or not (non-treated), epimastigotes were washed with PBS and loaded with MitoSOX (5&#xa0;&#x3bc;M, 30&#xa0;min), washed with PBS, and analyzed. The positive control was achieved by treating parasites with H<sub>2</sub>O<sub>2</sub> (300&#xa0;&#xb5;M, 10&#xa0;min), then washed and loaded with the probe.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-749476-g002.tif"/>
</fig>
</sec>
<sec id="s2_2">
<title>NFX Induces Enhanced MPX Protein Expression in WT Parasites</title>
<p>The content of MPX in WT parasites was evaluated following a 3-day treatment with NFX (7 and 14&#xa0;&#x3bc;M). As shown in <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>, MPX expression was significantly increased in NFX-treated parasites in a dose-dependent manner (2.5- and 3.5-fold increase) strengthening the hypothesis of a protective role of this enzyme toward the damage exerted by NFX. No changes in protein content were observed in the cytosolic peroxiredoxin (CPX) and other <italic>T. cruzi</italic> peroxiredoxin with holdase activity <italic>in vitro</italic> (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>) (<xref ref-type="bibr" rid="B50">Pi&#xf1;eyro et&#xa0;al., 2019</xref>) in agreement with the mitochondrial activation of NFX. Interestingly, NFX treatment leads to the generation of non-reducible (with freshly prepared DTT or phosphine) dimers and higher aggregates that were not observed with H<sub>2</sub>O<sub>2</sub> treatment (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>, arrows<bold>)</bold>. Moreover, an increase in MPX content and the same non-reducible MPX dimers were observed after a temperature challenge by growing parasites at 37&#xb0;C for 3&#xa0;days (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>, arrows). This shift in temperature occurs during the life cycle of <italic>T. cruzi</italic> when the insect-derived metacyclic trypomastigotes (28&#xb0;C) invade the vertebrate host (37&#xb0;C). Furthermore, in order to evaluate if the increase in MPX content is also induced by other anti-<italic>T. cruzi</italic> drugs (BZ, azasterol, ketoconazole), parasites were incubated for 3&#xa0;days with the IC<sub>50</sub> of each drug. Only BZ treatment enhanced the MPX content (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;S4</bold>
</xref>) in agreement with its mitochondrial-dependent NTR-I activation. BZ toxicity has been proposed to occur <italic>via</italic> reduced intermediates that covalently modified low molecular weight thiols and different macromolecules with no generation of reactive oxygen species (<xref ref-type="bibr" rid="B66">Trochine et&#xa0;al., 2014</xref>). The above results ruled out the generation of oxidative stress after NFX treatment, and we aimed to evaluate the protective role of the MPX holdase activity.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Increased expression of MPX but not cytosolic peroxiredoxin (CPX) in WT parasites exposed to NFX. <bold>(A)</bold> Epimastigotes (WT) were grown in the absence or presence of NFX (7&#x2013;14<bold>&#xa0;</bold>&#xb5;M, 3&#xa0;days). After treatment, parasites (1&#xa0;&#xd7;&#xa0;10<sup>8</sup> cells) were collected, washed, and resuspended in PBS buffer containing NEM (10&#xa0;mM). Total protein extract (50&#xa0;&#x3bc;g) was run on SDS-PAGE (12%) under reducing conditions (DTT, 1&#xa0;mM) and Western blot for MPX and CPX was performed as described. Parasites incubated with H<sub>2</sub>O<sub>2</sub> (300&#xa0;&#xb5;M, 30&#xa0;min) was performed as control. Right panel: Relative quantification of band intensity with respect to control condition. Results are means &#xb1; SEM of relative densitometric quantitation by LI-COR Image Studio of at least three independent determinations; ** denotes statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.01). For quantification, Coomassie blue staining of the different samples (50&#xa0;&#x3bc;g) was used as loading control (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;S3</bold>
</xref>). NT, non-treated. NFX: treated 3&#xa0;days with NFX 7 or 14&#xa0;&#x3bc;M. H<sub>2</sub>O<sub>2</sub>: treated with H<sub>2</sub>O<sub>2</sub> 300&#xa0;&#x3bc;M for 10&#xa0;min. <bold>(B)</bold> Evaluation of mitochondrial MPX content in parasites grown for 3&#xa0;days in the presence of NFX [as in panel <bold>(A)</bold>] or at 37&#xb0;C. Western blot anti-MPX of protein extract was performed as in panel <bold>(A)</bold>. Recombinant MPX (rMPX, 5&#xa0;&#xb5;g) was run as control. NT, non-treated. NFX: treated 3&#xa0;days with NFX 7&#xa0;&#x3bc;M. 37&#xb0;C: grown 3&#xa0;days at 37&#xb0;C. MPXr, recombinant MPX. <bold>(C)</bold> Western blot anti-CPX of protein extract of control parasites or grown in the presence of NFX, performed as in panel <bold>(A)</bold>. NT, non-treated. NFX: treated 3&#xa0;days with NFX 7&#xa0;&#x3bc;M.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-749476-g003.tif"/>
</fig>
</sec>
<sec id="s2_3">
<title>
<italic>Trypanosoma cruzi</italic> Mitochondrial Peroxiredoxin Exhibits Holdase Activity</title>
<p>To assess whether MPX is able to function as holdase, preventing protein aggregation, it was first tested if recombinant enzyme could enhance the refolding of GFP. This fluorescent protein loses its structure after a short incubation at low pH and, therefore, its fluorescence properties. GFP can refold and regain its fluorescent structure at a slow rate in the absence of holdases; however, when the refolding buffer is supplemented with a protein that can act as a holdase, the process of refolding is accelerated (<xref ref-type="bibr" rid="B27">Mares et&#xa0;al., 2011</xref>). As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, the presence of recombinant MPX (rMPX, 50&#xa0;&#x3bc;M) causes GFP (0.5&#xa0;&#xb5;M) to recover its fluorescence more efficiently. As a control condition, incubation of unfolded GFP with an unrelated protein that lacks holdase activity [bovine serum albumin (BSA), 50&#xa0;&#x3bc;M) did not accelerate GFP refolding (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). In case of MPX, as described also for CPX (<xref ref-type="bibr" rid="B50">Pi&#xf1;eyro et&#xa0;al., 2019</xref>), holdase activity is not dependent on its redox state since both reduced and oxidized rMPX and the mutant lacking the peroxidatic cysteine (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;S5</bold>
</xref>) exhibit holdase activity (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Holdase activity of recombinant MPX. <bold>(A)</bold> Holdase activity of recombinant MPX (rMPX) was evaluated with the GFP refolding assay as described in the <italic>Materials and Methods</italic> section. GFP was incubated in refolding buffer alone or in the presence of recombinant MPX (rMPX, 50&#xa0;&#x3bc;M) or BSA (50&#xa0;&#x3bc;M). * denotes statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.05) and ** statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.01) compared with GFP alone (two-tailed unpaired <italic>t</italic>-test). <bold>(B)</bold> Holdase activity of recombinant MPX (rMPX, 50&#xa0;&#x3bc;M) in its reduced (DTT, 1mM) and oxidized state. * Denotes statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.05) and ** statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.01) compared with GFP alone (two-tailed unpaired <italic>t</italic>-test). There were no statistical differences between reduced and oxidized MPX.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-749476-g004.tif"/>
</fig>
<p>Holdase activity of some peroxiredoxins may rely on the gaining of higher structure levels with the formation of high molecular weight aggregates (<xref ref-type="bibr" rid="B75">Wood et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B21">Jang et&#xa0;al., 2004</xref>). In this sense, we evaluated whether parasite MPX could acquire high molecular weight aggregates after NFX incubation (7&#xa0;&#xb5;M, 3&#xa0;days). For this purpose, the protein extracts from non-treated and NFX-treated parasites were separated on native 8% polyacrylamide gels and subjected to Western blot with anti-MPX antibody. As shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>, NFX and/or temperature treatment (37&#xb0;C, 3&#xa0;days) leads to the formation of high molecular weight aggregates of MPX that were not observed in non-treated parasites. Then, we enriched the parasites extracts (NFX-treated or not) in high molecular protein or protein aggregates (&gt;100&#xa0;kDa) and used these enriched extracts to search for MPX holdase activity in order to establish if NFX treatment could lead MPX to gain this function. As seen in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>, this high molecular weight extract obtained from WT parasites treated with NFX displayed an enhancement in holdase activity with respect to non-treated parasites. In the MPX-overexpressing parasites, no difference in holdase activity was observed between non-treated and NFX-treated parasite extracts (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). This result indicates that NFX treatment of WT parasites causes MPX to enhance its expression and to gain holdase activity probably due to NFX-induced mitochondrial protein mis-/unfolding and that this function is related to the protective role of MPX toward NFX. In this line, NFX-treated parasites presented enhanced levels of protein ubiquitination (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>) and a significant increase in the mitochondrial proteosome-related protease activity (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>), suggesting that mitochondrial protein damage is being elicited by NFX metabolism.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Holdase activity of parasite MPX. <bold>(A)</bold> Mitochondrial peroxiredoxin ability to acquire high molecular weight aggregates in parasite was studied by native gel electrophoresis (8%) and Western blot anti-MPX of total protein extract (obtained as in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>, 50&#xa0;&#x3bc;g) of WT or MPX-overexpressing parasites grown in the absence (non-treated, NT) or presence of NFX (NFX-treated, 7&#xa0;&#x3bc;M, 3&#xa0;days; left panel) or at 37&#xb0;C (grown 3&#xa0;days at 37&#xb0;C; right panel). NT, non-treated. NFX: treated 3&#xa0;days with NFX 7&#xa0;&#x3bc;M. 37&#xb0;C: grown 3&#xa0;days at 37&#xb0;C. <bold>(B, C)</bold> High molecular weight protein extract (&gt;100&#xa0;kDa) was obtained from epimastigotes (1&#xa0;&#xd7;&#xa0;10<sup>9</sup>) non-treated or treated with NFX (7&#xa0;&#x3bc;M, 3&#xa0;days) as described in the <italic>Materials and Methods</italic> section. Level of holdase activity in high molecular weight fraction (300&#xa0;&#x3bc;g) was assessed by GFP refolding assay. <bold>(B)</bold> WT parasite extracts, non-treated and treated with NFX. <bold>(C)</bold> MPX-overexpressing parasite extracts non-treated and treated with NFX. ** denotes statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.01) compared with WT non-treated parasite extracts (two-tailed unpaired <italic>t</italic>-test). There were no statistical differences between extracts from MPX parasites non-treated and treated with NFX.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-749476-g005.tif"/>
</fig>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Increased protein ubiquitination and mitochondrial protease activity in WT parasites treated with NFX. <bold>(A)</bold> Evaluation of proteins conjugated to ubiquitin in WT parasites non-treated (NT) or treated with NFX (7&#xa0;&#x3bc;M, 3&#xa0;days) or grown at 37&#xb0;C (3&#xa0;days). Following treatment, parasites were collected by centrifugation and washed in PBS, and the protein extract was obtained as described. Total protein extract (50&#xa0;&#x3bc;g) was run on SDS-PAGE (12%) and Western blot anti-ubiquitin (Abcam/ab7780) was performed. <bold>(B)</bold> Protein extracts derived from parasites (1&#xa0;&#xd7;&#xa0;10<sup>8</sup>) grown in the absence or presence of NFX were tested for proteosome-related protease activity. Total protein extracts (300&#xa0;&#x3bc;g) were incubated at 28&#xb0;C in buffer Tris&#x2013;HCl pH 7.4 containing 50&#xa0;&#x3bc;M of the fluorogenic substrate Suc-Leu-Leu-Val-Tyr-AMC (50&#xa0;&#x3bc;M). AMC release was followed fluorometrically at <italic>&#x3bb;</italic>
<sub>ex</sub>&#xa0;=&#xa0;365&#xa0;nm and <italic>&#x3bb;</italic>
<sub>em</sub>&#xa0;=&#xa0;440&#xa0;nm. * denotes statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.05) compared with WT non-treated parasite extracts (two-tailed unpaired <italic>t</italic>-test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-749476-g006.tif"/>
</fig>
</sec>
<sec id="s2_4">
<title>Selective Inhibition of MPX Peroxidase But Not Holdase Activity by Conoidin A</title>
<p>With the aim to evaluate the role of peroxidase vs. holdase activity of MPX during macrophage infections, we examined the effects of conoidin A (CA), a previously reported cell-permeable covalent inhibitor of the peroxidase activity of some peroxiredoxins, by alkylating or crosslinking the catalytic cysteines (<xref ref-type="bibr" rid="B25">Liu et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B4">Brizuela et&#xa0;al., 2014</xref>). We first search for the ability of CA (100&#xa0;&#xb5;M, 1&#xa0;h) to produce MPX crosslinking. As shown in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>, Western blot of recombinant MPX treated for 1&#xa0;h with CA (100&#xa0;&#xb5;M) revealed the presence of non-reducible aggregates of MPX indicating that CA reacts and crosslinks recombinant MPX. Then, peroxidase activity of recombinant pre-reduced rMPX (5&#xa0;&#xb5;M), control or previously incubated with CA (100&#xa0;&#xb5;M), was followed by the inhibition of boronate oxidation (CBA, 50&#xa0;&#xb5;M) in the presence of controlled fluxes of peroxynitrite generated by SIN-1 (3.5&#xa0;&#xb5;M ONOO<sup>&#x2212;</sup>/min). We took advantage of the practicality of evaluating peroxidase activity through this fast and simple assay, given that peroxynitrite is a key mediator of parasite control in the context of infection (<xref ref-type="bibr" rid="B1">Alvarez et&#xa0;al., 2011</xref>). MPX was able to inhibit ONOOH-dependent CBA oxidation (~100&#xa0;s, arrow), whereas when MPX was previously incubated with CA, peroxidase activity was inhibited, and CBA oxidation occurred with practically the same characteristics as when MPX was not added to the assay (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). Finally, holdase activity was evaluated in MPX previously incubated with CA, which showed the same ability to aid in the GFP refolding than that of non-treated reduced MPX. Thus, CA treatment was unable to inhibit holdase activity, confirming that CA inhibits peroxidase but not holdase activity in recombinant MPX.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Peroxidase but not holdase activity inhibition by conoidin A on recombinant MPX. <bold>(A)</bold> Recombinant MPX (5&#xa0;&#x3bc;M) treated with conoidin A as described in the <italic>Materials and Methods</italic> section. Samples were run on SDS-PAGE (12%) under reducing (DTT, 1&#xa0;mM) or non-reducing conditions. Coomassie blue staining is shown. Conoidin A resulted in the formation of non-reducible adducts of MPX. <bold>(B)</bold> Measurement of peroxidase activity of previously reduced MPX (5&#xa0;&#x3bc;M) control or incubated with conoidin A by its ability to decompose peroxynitrite produced by SIN-1 (2&#xa0;mM, 3&#xa0;&#x3bc;M/min), in the presence of CBA (50&#xa0;&#xb5;M). CBA oxidation was followed fluorometrically at <italic>&#x3bb;</italic>
<sub>ex</sub>&#xa0;=&#xa0;365&#xa0;nm and <italic>&#x3bb;</italic>
<sub>em</sub>&#xa0;=&#xa0;440&#xa0;nm. Arrow indicates the time lapse for non-treated MPX peroxynitrite detoxification (i.e., ~100&#xa0;s), and dotted arrow indicates the time lapse for CA-treated MPX (i.e., ~180&#xa0;s). <bold>(C)</bold> Measurement of holdase activity by the GFP refolding assay of recombinant MPX (50&#xa0;&#x3bc;M) (squares) and recombinant MPX pretreated with conoidin A (triangles); control (circles) is the spontaneous refolding of GFP. There were no statistical differences between non-treated MPX and CA-treated MPX.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-749476-g007.tif"/>
</fig>
</sec>
<sec id="s2_5">
<title>MPX Peroxidase Activity Is Important for Parasite Survival in Macrophage Infections</title>
<p>In order to clearly state the role of MPX peroxidase activity during macrophage invasion, we performed infection experiments in naive and immunostimulated macrophages for peroxynitrite generation. As shown in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>, overexpression of MPX rises by 2-fold the ability of parasites to establish the infection in both naive and activated macrophages. This result indicates the crucial role of MPX for parasite survival. In order to discriminate the relative weight of peroxidase vs. holdase activity during the macrophage infection process, we conducted experiments using trypomastigotes preincubated with CA. First, we evaluated the ability of this inhibitor to react with parasite MPX. For this, epimastigotes were exposed to CA (100&#xa0;&#xb5;M, 1&#xa0;h) and protein extracts subjected to Western blot anti-MPX and anti-CPX under reducing and non-reducing conditions. As shown in <xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8B</bold>, <bold>C</bold>
</xref>, non-reducible MPX and CPX adducts were formed in the presence of CA (arrows) as previously described for other peroxiredoxins (<xref ref-type="bibr" rid="B38">Nguyen et&#xa0;al., 2013</xref>). This peroxiredoxin CA-induced adducts were stable for at least 4&#xa0;h; adducts were no longer observed 24&#xa0;h later indicating the ability of the parasite to degrade them. Then, CA-treated parasites were used to infect naive macrophages; since the parasite resides in the macrophage phagosome for at least 2&#xa0;h, peroxiredoxin adducts are still present during parasite internalization in the macrophage phagosome. Finally, CA treatment leads to a significant decrease in the number of intracellular amastigotes following 24&#xa0;h of infection (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8D</bold>
</xref>). This means that peroxidase activity of peroxiredoxins is crucial for parasite survival during macrophage infection, reinforcing the importance of the peroxidase activity of peroxiredoxins in parasite resistance and evasion of the macrophage-derived oxidative assault.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>MPX peroxidase activity is required for trypomastigotes to thrive in macrophage infections. <bold>(A)</bold> Naive or immunostimulated macrophages were infected with culture-derived trypomastigotes (WT or MPX overexpressers) at a parasite:cell ratio of 3:1. Following 2&#xa0;h, non-internalized parasites were removed and infection proceeded for 24&#xa0;h. Intracellular amastigotes were counted fluorometrically (DAPI staining) with at least 1,000 macrophages/condition recorded. Results are expressed as the infection index of at least three experiments calculated expressing the number of amastigotes/100 macrophages relative to WT infection. ** and * denote statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.01 and <italic>p</italic>&#xa0;&lt;&#xa0;0.05, respectively) with respect to WT control condition. <bold>(B, C)</bold> Western blot anti-MPX and anti-CPX of protein extracts of culture-derived trypomastigotes treated with conoidin A (100&#xa0;&#x3bc;M, 1&#xa0;h) in DMEM medium at 37&#xb0;C. Total protein extracts were obtained as described and samples containing 50&#xa0;&#x3bc;g protein were analyzed by SDS-PAGE (12%) under reducing (DTT, 1&#xa0;mM) or non-reducing conditions. <bold>(D)</bold> Conoidin-treated trypomastigotes [the same conditions as panel <bold>(B)</bold>] were used to infect naive macrophages as described in panel <bold>(A)</bold>, and intracellular amastigotes were counted following 24&#xa0;h of infection. Results are expressed as the infection index calculated expressing the number of amastigotes/100 macrophages relative to WT control. ** denotes statistical differences (<italic>p</italic>&#xa0;&lt;&#xa0;0.01).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-749476-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s3" sec-type="discussion">
<title>Discussion</title>
<p>The importance of enzymes of the antioxidant network for parasite protection toward exogenous or endogenously derived reactive oxygen and nitrogen species has been previously documented (<xref ref-type="bibr" rid="B44">Piacenza et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B46">Piacenza et&#xa0;al., 2013</xref>), and in particular, the role of peroxiredoxins in the protection of the parasite against macrophage-derived oxidants has been established (<xref ref-type="bibr" rid="B45">Piacenza et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B1">Alvarez et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B49">Pi&#xf1;eyro et&#xa0;al., 2011</xref>). However, little is known regarding the possibility that, as in other organisms, <italic>T. cruzi</italic> peroxiredoxins have other roles in dealing with different kinds of stress. Herein, we showed the involvement of MPX in protecting parasites from NFX toxicity. The observations that increased levels of MPX help parasites to overcome the toxicity of NFX (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A</bold>
</xref> and <xref ref-type="fig" rid="f2">
<bold>2A</bold>
</xref>) and that incubation in these conditions causes overexpression of MPX in wild-type parasites (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>) but not that of the cytosolic CPX (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>) clearly indicate that MPX is involved in the parasite protective response toward the drug. Overexpression of MPX was also observed in BZ-treated parasites (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S4</bold>
</xref>), which may be explained by the fact that BZ metabolism relies on the same mitochondrial nitro reductase NTR-I (as for NFX activation), which means that the mitochondria is the first organelle affected by the action of these drugs (although each drug may have different targets). However, other drugs like ketoconazole and azasterol (<xref ref-type="bibr" rid="B32">McCabe et&#xa0;al., 1984</xref>; <xref ref-type="bibr" rid="B12">Goad et&#xa0;al., 1989</xref>; <xref ref-type="bibr" rid="B68">Urbina et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B62">de Souza and Rodrigues, 2009</xref>) that inhibit <italic>T. cruzi</italic> growth by affecting sterol synthesis did not affect the MPX content in parasites (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S4</bold>
</xref>). This result points to the conclusion that MPX overexpression is a specific protective response that occurs when the mitochondria is faced with stress.</p>
<p>Since different hypotheses were built in order to explain NFX toxicity, we first assessed the possibility that the ability of MPX to detoxify peroxides was the basis for the observed protection. Nonetheless, we did not observe any evidence of a significant increase in reactive oxygen species production and/or mitochondrial superoxide generation in wild-type parasites treated with NFX (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1B</bold>
</xref>, <xref ref-type="fig" rid="f2">
<bold>2B</bold>
</xref>), so we could not conclude that peroxidase activity explains the protection conferred by MPX toward NFX in this experimental condition. These results are in agreement with previous reports that showed that NFX and BZ are activated by mitochondrial NTR-I in a sequential 2-electron reduction steps that does not involve the generation of reactive oxygen species (<xref ref-type="bibr" rid="B71">Wilkinson et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B7">Cerecetto and Gonz&#xe1;lez, 2011</xref>).</p>
<p>The protective role of <italic>L. infantum</italic> mitochondrial peroxiredoxin (<italic>Li</italic>mTXNPx) during thermal stress and also during macrophage infections was previously proposed. This protective role was fulfilled by the expression of a peroxidase inactive version of the enzyme (<xref ref-type="bibr" rid="B6">Castro et&#xa0;al., 2011</xref>). Taking this result into consideration and knowing the ability of <italic>T. cruzi</italic> CPX to prevent protein aggregation <italic>in vitro</italic> (<xref ref-type="bibr" rid="B50">Pi&#xf1;eyro et&#xa0;al., 2019</xref>), we consider the possibility that the protection conferred by MPX toward NFX may involve the alternative functions of peroxiredoxins, such as the yet unexplored holdase activity.</p>
<p>In this sense, we evaluated the ability of recombinant MPX to aid in GFP refolding and established that <italic>in vitro</italic> this enzyme increases the rate by which unfolded GFP regains its native structure (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Knowing that holdase activity of several peroxiredoxins is proposed to be modulated by the redox state of the protein, we evaluated MPX holdase activity in its reduced and oxidized state as well as for the catalytic mutant (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;S5</bold>
</xref>). Similar holdase activity was observed in both redox states of the enzyme (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>), in agreement with what was previously shown for <italic>T. cruzi</italic> cytosolic CPX (<xref ref-type="bibr" rid="B50">Pi&#xf1;eyro et&#xa0;al., 2019</xref>). The observation that recombinant MPX showed holdase activity (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>) prompted us to analyze whether MPX is able <italic>in vivo</italic> to acquire high molecular weight (HMW) oligomers that are related to holdase activity in other peroxiredoxins, including <italic>T. cruzi</italic> CPX (<xref ref-type="bibr" rid="B74">Wood et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B50">Pi&#xf1;eyro et&#xa0;al., 2019</xref>). We found that MPX can acquire this oligomeric structure in the parasite, and interestingly, HMW aggregates are significantly increased in NFX-treated parasites (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). These same MPX aggregates were observed in parasites under thermal stress, which suggest a connection between NFX and temperature challenge (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>).</p>
<p>After establishing that MPX has holdase activity <italic>in vitro</italic> and that in parasites it can acquire HMW oligomers that increase its abundance in response to NFX, we aimed to study if this is also accompanied by an increase in holdase activity. For this purpose, we measured holdase activity in the HMW protein extracts (&gt;100&#xa0;kDa) of parasites not treated and treated with NFX. For WT parasites in which an increase in MPX content was observed following NFX treatment, a significant increase in holdase activity with respect to untreated parasites was observed (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). This result first establishes MPX holdase activity <italic>in vivo</italic> and, second, could indicate that parasites increase and activate anti-aggregation systems in response to NFX, suggesting that the drug mitochondrial metabolism may generate a rise in damaged and/or unfolded proteins. Importantly, the MPX-overexpressing parasites with enhanced MPX content did not show an increase in holdase activity after NFX treatment suggesting that they can deal with the NFX unfolded protein damage response without the need to further increase MPX expression (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>).We have yet to establish the oligomerization state for MPX and the minimum level of MPX that allows the oligomerization needed to function as a holdase, considering that peroxiredoxins of trypanosomatids seem to have holdase activity in its decameric form (<xref ref-type="bibr" rid="B63">Teixeira et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B50">Pi&#xf1;eyro et&#xa0;al., 2019</xref>).</p>
<p>To evaluate if NFX causes the unfolding or misfolding of proteins tagging them for degradation, we search for protein ubiquitination and increase in protease activity after NFX treatment of WT parasites. We found an increase in protein ubiquitination and enhancement in proteosome-related protease activity following NFX treatment (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>
<bold>)</bold>, which may link NFX toxicity with the increase of MPX expression in WT parasites and the need to gain holdase activity to counteract the toxic effects. The unfolding of proteins could be a consequence of the production of reactive nitriles generated by NFX metabolism by parasite mitochondrial NTR-I, an enzyme that is not found in the vertebrate host (<xref ref-type="bibr" rid="B71">Wilkinson et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B7">Cerecetto and Gonz&#xe1;lez, 2011</xref>). This hypothesis is in agreement with the observation that MPX expression increases in parasites grown under thermal stress as previously reported (<xref ref-type="bibr" rid="B40">P&#xe9;rez-Morales et&#xa0;al., 2012</xref>) and as also observed in this work (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3B</bold>
</xref>, <xref ref-type="fig" rid="f5">
<bold>5A</bold>
</xref>). <italic>Trypanosoma cruzi</italic> life cycle entails multiple changes in environmental conditions such as temperature, pH, and oxidative stress. Parasites have to adapt to these varying environments in order to survive and be able to establish the infection. Besides the antioxidant enzyme system described by our group and others (<xref ref-type="bibr" rid="B45">Piacenza et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B51">Pi&#xf1;eyro et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B42">Piacenza et&#xa0;al., 2009b</xref>; <xref ref-type="bibr" rid="B29">Mart&#xed;nez et&#xa0;al., 2019</xref>), the parasite has evolved other mechanism to deal with stress such as molecular chaperones, which highlights the importance of maintaining protein homeostasis (<xref ref-type="bibr" rid="B60">Shonhai et&#xa0;al., 2011</xref>). The observations reported herein could indicate that NFX alters protein homeostasis in <italic>T. cruzi</italic> causing damage to the mitochondria and that the increase in MPX holdase activity could be part of the response to protein unfolding. The fact that thermal stress, known to require a chaperone response (<xref ref-type="bibr" rid="B59">Sanchez and Lindquist, 1990</xref>; <xref ref-type="bibr" rid="B16">H&#xfc;bel et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B19">J&#xe4;&#xe4;ttel&#xe4;, 1999</xref>), induces MPX overexpression as previously reported (<xref ref-type="bibr" rid="B40">P&#xe9;rez-Morales et&#xa0;al., 2012</xref>) and shown herein supports this hypothesis. Further work is required to characterize the alteration in proteostasis caused by NFX and if this is linked to the toxicity produced by the drug.</p>
<p>Taking into consideration the MPX holdase function described herein, it was considered whether this activity may be of relevance in the context of macrophage infection in which reactive oxygen and nitrogen species are being generated (<xref ref-type="bibr" rid="B1">Alvarez et&#xa0;al., 2011</xref>).</p>
<p>In an attempt to disclose the relevance of both MPX activities (peroxidase vs. holdase) and knowing that <italic>T. cruzi</italic> knockout parasites are extremely difficult to obtain, we evaluate the ability of CA as a possible inhibitor of peroxidase but not holdase activity, since it reacts with the peroxidatic cysteine that is not necessary for holdase activity (<xref ref-type="bibr" rid="B63">Teixeira et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B50">Pi&#xf1;eyro et&#xa0;al., 2019</xref>). First, we assessed if recombinant MPX reacts with CA which would generate the reported adducts inhibiting peroxidase but not holdase activity. MPX-CA treatment generates the non-reducible protein adducts and inhibits peroxidase activity, but this treatment does not affect MPX holdase activity (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>).</p>
<p>Previous studies from our group have shown the ability of MPX to cope with exogenous or endogenously produced H<sub>2</sub>O<sub>2</sub> and peroxynitrite (<xref ref-type="bibr" rid="B45">Piacenza et&#xa0;al., 2008</xref>), but until now, the potential protection conferred by MPX in macrophage infections is not studied. First, it was proven that MPX contents are important for parasite survival on both naive (H<sub>2</sub>O<sub>2</sub> production) and immune-stimulated macrophages for peroxynitrite generation (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). This result is in agreement with MPX peroxidase activity, since inside the phagosome the parasite is exposed to peroxynitrite and H<sub>2</sub>O<sub>2</sub> that can diffuse inside the internalized parasite reaching the parasite mitochondria (<xref ref-type="bibr" rid="B45">Piacenza et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B1">Alvarez et&#xa0;al., 2011</xref>), or alternatively, it can be generated inside the parasite by means of the diffusion of its precursors nitric oxide and superoxide radicals (<xref ref-type="bibr" rid="B42">Piacenza et&#xa0;al., 2009a</xref>; <xref ref-type="bibr" rid="B29">Mart&#xed;nez et&#xa0;al., 2019</xref>). Then, in order to assess the possibility to inhibit MPX peroxidase activity in the parasite, and whether this inhibition may influence <italic>T. cruzi</italic> ability to establish the infection, we first evaluated if CA generates MPX adducts <italic>in vivo.</italic> As shown in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>, CA also generates non-reducible covalent adducts of MPX <italic>in vivo</italic> similar to the effect observed in the recombinant protein (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>), indicating that CA is able to act <italic>in vivo.</italic> Unfortunately, CA acts in both <italic>T. cruzi</italic> peroxiredoxins, and thus, the unique role of MPX in macrophage infections is not disclosed (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>). Nevertheless, the role of the peroxidase and/or holdase activities of both peroxiredoxins can be addressed using this inhibitor. We found that CA-treated parasites have a diminished infection index (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8D</bold>
</xref>), showing the importance of peroxidase activity to overcome macrophage-derived oxidants in divergence to what was previously observed for <italic>Lm</italic> mitochondrial peroxiredoxin (<xref ref-type="bibr" rid="B6">Castro et&#xa0;al., 2011</xref>). This result does not discard the fact that MPX holdase activity could be relevant in the infection process. Ongoing experiments are focused on addressing the relevance of MPX in the context of NFX treatment during macrophage infections.</p>
<p>With the observation that MPX is overexpressed in wild-type parasites when exposed to NFX and BZ (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;S4</bold>
</xref>) and knowing that the mitochondrial metabolism of these drugs gives rise to different toxic and reactive intermediates (<xref ref-type="bibr" rid="B7">Cerecetto and Gonz&#xe1;lez, 2011</xref>; <xref ref-type="bibr" rid="B15">Hall and Wilkinson, 2012</xref>; <xref ref-type="bibr" rid="B66">Trochine et&#xa0;al., 2014</xref>), we propose that the increase in MPX expression observed may be caused by an enhancement in the modified/damaged macromolecules at the mitochondrial compartment. To further understand if MPX is a direct target for metabolites derived from NFX or if its overexpression is induced by other effects caused by the drug, further experiments need to be performed including the characterization of the adducts observed in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>. It was previously shown that there is a distinct MPX content among natural occurring strains and that it has a positive correlation with parasite virulence (<xref ref-type="bibr" rid="B42">Piacenza et&#xa0;al., 2009b</xref>). Taking into account that MPX overexpression protects parasites from NFX toxic effect (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>), we proposed that the MPX content may be one of the factors that contributes to the differences in NFX sensitivity reported for different <italic>T. cruzi</italic> strains (<xref ref-type="bibr" rid="B37">Murta et&#xa0;al., 1998</xref>).</p>
<p>In conclusion, our results demonstrate that MPX is able to function not only as an efficient peroxidase but also as a holdase, preventing protein aggregation. We observed that peroxidase function is crucial for macrophage infection, but MPX holdase activity may be relevant in other conditions, such as thermal or drug-related stress. We have yet to unravel how these two functions are modulated and which conditions could favor holdase activity. There are many factors proposed to impact on holdase activity of peroxiredoxins, such as redox state, ion concentration, and thermal activation (<xref ref-type="bibr" rid="B74">Wood et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B36">Morais et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B64">Teixeira et&#xa0;al., 2019</xref>). Our results point to the fact that holdase activity of MPX is not related to its redox state. However, given that we observed overexpression and high molecular weight aggregates after thermal stress, it would be interesting to deepen our understanding of the effect of temperature on MPX function during the infection process.</p>
</sec>
<sec id="s4" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s4_1">
<title>Parasite Culture</title>
<p>
<italic>Trypanosoma cruzi</italic> epimastigotes from the CL-Brener (wild type, WT) were cultured at 28&#xb0;C in brain&#x2013;heart infusion (BHI) medium as described previously (<xref ref-type="bibr" rid="B47">Piacenza et&#xa0;al., 2001</xref>). Parasites overexpressing MPX were obtained as previously described and cultured in BHI containing geneticin (G418, 200&#xa0;&#x3bc;g/ml). Briefly, the complete gene sequences of the enzyme were cloned into the trypanosomal vector pTEX-9E10 (Invitrogen, Massachusetts, United States) and a ligation was performed to insert a c-Myc-derived epitope (9E10) in-frame at the 3&#x2032; end of the genes to produce the construct pTEX-MPX-9E10 (<xref ref-type="bibr" rid="B73">Wilkinson et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B45">Piacenza et&#xa0;al., 2008</xref>). Peroxidase activity of MPX was reported to be &#x223c;1.9 higher in overexpressing cells (<xref ref-type="bibr" rid="B73">Wilkinson et&#xa0;al., 2000</xref>). The increase in MPX expression as well as mitochondrial localization of the protein in the transfected parasites (&#x223c;4 times) is shown in the <bold>Supplementary Material</bold> (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1</bold>
</xref>).</p>
</sec>
<sec id="s4_2">
<title>Growth Curves With Nifurtimox</title>
<p>Epimastigotes (1&#xa0;&#xd7;&#xa0;10<sup>6</sup> cells/ml starting culture condition) were grown in BHI medium at 28&#xb0;C for 5&#xa0;days in the absence or presence of NFX (7&#xa0;&#x3bc;M, Sigma). The density of the cultures was evaluated by absorbance at 600&#xa0;nm every 24&#xa0;h (Cary UV-Vis spectrophotometer, Agilent). In order to compare different growth curves, we used the parasite proliferation index in which absorbance at 600&#xa0;nm is expressed relative to the <italic>A</italic>
<sub>600&#xa0;nm</sub> at the first day of the experiments, and the graphs obtained with this index are plotted as mean &#xb1; SD of three independent determinations.</p>
</sec>
<sec id="s4_3">
<title>Mitochondrial Membrane Potential</title>
<p>Rhodamine 123 (RH123, Invitrogen), which accumulates in the mitochondria in a potential-dependent manner, was used as a flow cytometer probe to assess mitochondrial membrane potential. Non-treated parasites (1&#xa0;&#xd7;&#xa0;10<sup>7</sup> cells) or parasites treated with NFX were washed in PBS and loaded with 5&#xa0;&#x3bc;g/ml RH123 for 15&#xa0;min at 28&#xb0;C, washed in PBS, and analyzed by a flow cytometer (FACS-Calibur, Becton Dickinson). FCCP (trifluoromethoxy carbonylcyanide phenylhydrazone, 1&#xa0;&#x3bc;M, Sigma) was used as a positive control for mitochondrial depolarization. In order to compare different conditions, the M1 region of low RH123 fluorescence (associated with mitochondrial depolarization) was defined.</p>
</sec>
<sec id="s4_4">
<title>Dihydrorhodamine Oxidation and BSO Treatment</title>
<p>After the different treatments, parasites (1&#xa0;&#xd7;&#xa0;10<sup>7</sup> cells) were collected by centrifugation and incubated for 30&#xa0;min at 28&#xb0;C in dPBS containing DHR (50&#xa0;&#x3bc;M, Molecular Probes). Then, cells were washed in dPBS in order to eliminate non-incorporated DHR. Detection of intracellular RH123, the oxidation product of DHR, was performed after exposure to the different experimental conditions using black 96-well plates and a fluorescence plate reader at 28&#xb0;C (Varioskan Flash, Thermo Scientifics) at <italic>&#x3bb;</italic>
<sub>ex</sub>&#xa0;=&#xa0;485&#xa0;nm and <italic>&#x3bb;</italic>
<sub>em</sub>&#xa0;=&#xa0;520&#xa0;nm. Overnight incubation with BSO 500&#xa0;&#xb5;M, an inhibitor of glutathione synthesis, was used to decrease parasite low molecular thiols which reduces parasite ability to detoxify H<sub>2</sub>O<sub>2</sub> (<xref ref-type="bibr" rid="B65">Thomson et&#xa0;al., 2003</xref>).</p>
</sec>
<sec id="s4_5">
<title>Low Molecular Weight Thiol Quantification</title>
<p>Parasite GSH and T(SH)<sub>2</sub> levels were quantified in epimastigotes (WT and MPX overexpressers) incubated or not with NFX every day, for 5&#xa0;days. Parasites were collected and washed in PBS and resuspended at a cell density of 1&#xa0;&#xd7;&#xa0;10<sup>9</sup> cells/ml in 100&#xa0;&#x3bc;l HEPES buffer (40&#xa0;mM, pH 8.0) containing monobromobimane (0.2&#xa0;mM). Following incubation at 70&#xb0;C for 3&#xa0;min, protein precipitation was performed with methanesulfonic acid (4&#xa0;M, 100&#xa0;&#x3bc;l) for 2&#xa0;h on ice and centrifugation at 13,000<italic>g</italic> for 30&#xa0;min was also performed. Non-protein thiols were separated by reverse phase ion-pairing HPLC on an Agilent C18 column and analyzed through fluorometric detection as previously described (<xref ref-type="bibr" rid="B23">Krauth-Siegel et&#xa0;al., 1995</xref>). Quantitation and validation were accomplished using T(SH)<sub>2</sub> (kindly provided by Luise Krauth-Siegel) and GSH standards (Sigma) and results expressed as nmol/10<sup>8</sup> parasites.</p>
</sec>
<sec id="s4_6">
<title>Parasite Extracts and Western Blotting</title>
<p>Epimastigotes treated or not with NFX (3&#x2013;5&#xa0;days) were collected at 2,000<italic>g</italic> for 10&#xa0;min at 25&#xb0;C, washed, and resuspended in PBS. Lysis was accomplished by freeze and thaw cycles in liquid nitrogen, the extract was centrifuged at 12,000<italic>g</italic> for 30&#xa0;min at 4&#xb0;C, and the supernatant was collected. For the enrichment in the parasite high molecular weight aggregates, cell extracts of 1&#xa0;&#xd7;&#xa0;10<sup>9</sup> parasites were filtered using an Amicon<sup>&#xae;</sup> Ultra-0.5&#xa0;ml Centrifugal Filter Unit with 100&#xa0;kDa cutoff.</p>
<p>Parasite extracts were run on polyacrylamide gels (native, 8% or SDS, 12%) under reducing (DTT, 1&#xa0;mM) or non-reducing conditions using loading buffer without or with SDS [30&#xa0;mM Tris&#x2013;HCl, pH 6.6, 1% (w/v) SDS, and 5% (v/v) glycerol]. Loading buffer was added to the supernatant and samples were stored at&#xa0;&#x2212;20&#xb0;C until used. Samples were electroblotted into nitrocellulose membranes and equal protein loading was confirmed by Ponceau or Coomassie blue staining. Membranes were blocked in non-fat dry milk (5% in PBS, 1&#xa0;h) and probed with anti-<italic>Tc</italic>MPX and anti-<italic>Tc</italic>CPX antibodies [kindly provided by Dr. Carlos Robello (<xref ref-type="bibr" rid="B51">Pi&#xf1;eyro et&#xa0;al., 2008</xref>)] and anti-ubiquitin antibody (Abcam/ab7780). Reactive proteins were visualized by incubating with secondary antibodies IRE-Dye 800 and/or 680 (LI-COR Biosciences) diluted 1:15,000 (LI-COR Biosciences) and visualized using an infra-red analyzer (Odyssey, LI-COR Biosciences). Band intensity was measured using the program Li-COR Image Studio.</p>
</sec>
<sec id="s4_7">
<title>Purification of Recombinant Proteins</title>
<p>
<italic>Escherichia coli</italic> (BL21 strain) transfected with plasmid containing either His-tagged, MPX, MPX-C81S (mutation of the peroxidatic cysteine), or roGFP (kindly provided by Dr. Shane Wilkinson, Dra. Dolores Pi&#xf1;eyro, and Dr. Marcelo Comini, respectively) both with ampicillin resistance was grown in terrific broth to an optical density at 600&#xa0;nm between 0.6 and 0.8&#xa0;AU. The expression of the enzymes was induced by addition to the culture of isopropyl-&#x3b2;-D-thiogalactopyranoside (IPTG, 1&#xa0;mM). Following an overnight incubation at 22&#xb0;C, the bacteria were collected by centrifugation at 3,000<italic>g</italic>, resuspended in lysis buffer, and sonicated (6 cycles, 1&#xa0;min each). The lysate was centrifuged 30&#xa0;min at 12,000<italic>g</italic> and 4&#xb0;C. The supernatant was collected for purification by affinity chromatography using a nickel column and following supplier instructions (HiTrap Chelating HP, GE Healthcare). Protein elution was monitored by absorbance at 280&#xa0;nm and the purity of the fractions analyzed by SDS-PAGE with Coomassie blue staining.</p>
</sec>
<sec id="s4_8">
<title>Evaluation of Holdase Activity</title>
<p>Chaperone activity was evaluated as previously described (<xref ref-type="bibr" rid="B27">Mares et&#xa0;al., 2011</xref>). Briefly, green fluorescent protein (GFP) is unfolded by incubation with HCl (62.5&#xa0;mM) in denaturation buffer [Tris&#x2013;HCl 50&#xa0;mM pH&#xa0;=&#xa0;7.5, containing EDTA (0.3&#xa0;mM) and DTT (1&#xa0;mM)] for 1&#xa0;min and transferred to freshly prepared refolding buffer [Tris&#x2013;HCl 50&#xa0;mM pH 7.5, containing MgCl<sub>2</sub> (25&#xa0;mM), KCl (100&#xa0;mM), and DTT (0.3&#xa0;mM)] at a final GFP concentration of 0.5&#xa0;&#xb5;M. GFP refolding is monitored fluorometrically (<italic>&#x3bb;</italic>
<sub>ex</sub>&#xa0;=&#xa0;485&#xa0;nm, <italic>&#x3bb;</italic>
<sub>em</sub>&#xa0;=&#xa0;538&#xa0;nm) using a microplate reader (Varioskan Flash, Thermo Scientific). For the evaluation of holdase activity of recombinant MPX (rMPX), the protein was previously reduced (or not, oxidized state) by incubation with DTT (1&#xa0;mM) for 1&#xa0;h. DTT was then removed by Micro Bio-Spin&#x2122; Size Exclusion Spin Columns (Bio-Rad). Protein was quantified by absorbance at 280&#xa0;nm, and 50&#xa0;&#xb5;M of rMPX was used in the assays. For the assessment of the holdase activity in the high molecular weight protein extracts, these were obtained as described from 1&#xa0;&#xd7;&#xa0;10<sup>9</sup> parasites, and the protein extract obtained (300&#xa0;&#x3bc;g) was used in the GFP refolding assay. Bovine serum albumin (BSA, 50&#xa0;&#x3bc;M) that lacks holdase activity was used as control.</p>
</sec>
<sec id="s4_9">
<title>Assessment of Peroxidase Activity</title>
<p>Peroxidase activity was evaluated indirectly by a competition assay between peroxynitrite-dependent oxidation of coumarin boronic acid (CBA, <italic>k</italic> ~ 1 &#xd7; 10<sup>6</sup> M<sup>&#x2212;1</sup> s<sup>&#x2212;1</sup>; pH 7.4 and 25&#xb0;C) that yields a fluorescent product (coumarin) in the presence and/or absence of rMPX (<italic>k</italic> = 1.8 &#xd7; 10<sup>7</sup> M<sup>&#x2212;1</sup> s<sup>&#x2212;1</sup> at pH 7.4, 25&#xb0;C) (<xref ref-type="bibr" rid="B49">Pi&#xf1;eyro et al., 2011</xref>). Briefly, peroxynitrite released by 3-morpholinosydnonimine hydrochloride (SIN-1, 2 mM) was determined by measuring DHR oxidation (<italic>&#x3f5;</italic>
<sub>500</sub> = 78,800 M<sup>&#x2212;1</sup> cm<sup>&#x2212;1</sup>) as described previously (<xref ref-type="bibr" rid="B54">Radi et al., 2001</xref>). Peroxynitrite-dependent (peroxynitrite flux ~ 3 &#xb5;M/min) oxidation of CBA (50 &#xb5;M) was followed at <italic>&#x3bb;</italic>
<sub>ex</sub> = 332 nm and <italic>&#x3bb;</italic>
<sub>em</sub>= 470 nm in the presence or absence of pre-reduced rMPX (5 &#xb5;M). The decomposition of peroxynitrite by MPX reduces the oxidant generation of coumarin in the first 100 s (lag phase observed in the presence of rMPX with respect to SIN-1 condition) and, thus, CBA oxidation.</p>
</sec>
<sec id="s4_10">
<title>Proteosome-Related Protease Activity</title>
<p>Endopeptidase activity was measured using the fluorogenic substrate Suc-Leu-Leu-Val-Tyr-AMC (CAS 94367-21-2, Santa Cruz), and the hydrolysis of this peptide was followed by the fluorescence of AMC (7-amino-4-methylcoumarin, <italic>&#x3bb;</italic>
<sub>ex</sub>&#xa0;=&#xa0;365&#xa0;nm; <italic>&#x3bb;</italic>
<sub>em</sub>&#xa0;=&#xa0;440&#xa0;nm), which is released upon protease activity. Endopeptidase activity in parasite protein extract was evaluated as follows: parasites (3&#xa0;&#xd7;&#xa0;10<sup>8</sup> cells) were collected after NFX treatment (3&#xa0;days, 7&#xa0;&#xb5;M), washed in PBS, and lysed by freeze and thaw cycles; the extract was centrifuged at 12,000<italic>g</italic> for 30&#xa0;min at 4&#xb0;C; and the supernatant was collected. Endopeptidase activity in the supernatant (150&#xa0;&#x3bc;g) was measured at 28&#xb0;C in buffer Tris&#x2013;HCl pH 7.4 by the increase in fluorescence of AMC in a microplate reader (Varioskan Flash, Thermo Scientific). The initial concentration of fluorogenic substrate was 50&#xa0;&#x3bc;M.</p>
</sec>
<sec id="s4_11">
<title>Parasite Differentiation (Metacyclogenesis)</title>
<p>Metacyclic trypomastigotes were obtained by chemical differentiation as described previously (<xref ref-type="bibr" rid="B18">Isola et&#xa0;al., 1986</xref>; <xref ref-type="bibr" rid="B42">Piacenza et&#xa0;al., 2009b</xref>). Briefly, epimastigotes from a 5-day culture were collected by centrifugation at 800<italic>g</italic> for 10&#xa0;min at 25&#xb0;C, washed, and resuspended in 10&#xa0;ml TAU (triatomine artificial urine) [NaCl, 190&#xa0;mM; KCl, 17&#xa0;mM; MgCl<sub>2</sub>, 2&#xa0;mM; CaCl<sub>2</sub>, 2&#xa0;mM; sodium phosphate buffer, 8&#xa0;mM (pH 6.0); and sodium bicarbonate, 0.035%] at 3&#xa0;&#xd7;&#xa0;10<sup>8</sup> cells/ml. After incubation at 28&#xb0;C for 2&#xa0;h, the parasites were transferred and diluted in TAU3AAG (TAU three amino acids plus glucose) medium (TAU, pH 6.0) supplemented with L-proline, 10&#xa0;mM; L-glutamate, 50&#xa0;mM; L-aspartate, 10&#xa0;mM; and L-glucose, 10&#xa0;mM to 3&#xa0;&#xd7;&#xa0;10<sup>6</sup> cells/ml, following incubation for 96&#xa0;h at 28&#xb0;C as described previously (<xref ref-type="bibr" rid="B3">Bonaldo et&#xa0;al., 1988</xref>).</p>
</sec>
<sec id="s4_12">
<title>Conoidin A Treatment of Recombinant MPX and Parasites</title>
<p>For the inhibition assays, recombinant MPX was reduced by incubation with DTT 1&#xa0;mM for 1&#xa0;h. Then, the reducing agent was removed by Bio-Rad Micro Bio-Spin&#x2122; Size Exclusion Spin Columns (Bio-Rad). Reduced rMPX was incubated with CA 100&#xa0;&#xb5;M for 1&#xa0;h, and after incubation, the excess of the inhibitor was removed by Bio-Rad Micro Bio-Spin&#x2122; Size Exclusion Spin Columns (Bio-Rad).</p>
<p>To evaluate the inhibition of parasite peroxiredoxin, epimastigotes or trypomastigotes were collected and resuspended in medium (BHI or DMEM) at a density of 1&#xa0;&#xd7;&#xa0;10<sup>8</sup> cells/ml. CA was added up to a concentration of 100&#xa0;&#xb5;M and incubated for further 30&#xa0;minutes at 28&#xb0;C (epimastigotes) or 37&#xb0;C (trypomastigotes). After incubation, parasites were washed with PBS, collected, and used in Western blot or infection assays. The ability of CA to crosslink rMPX was evaluated by SDS-PAGE and Coomassie staining under reducing and non-reducing conditions (freshly prepared DTT and/or phosphine, 1&#xa0;mM). In parasites, the crosslink was evaluated by SDS-PAGE followed by Western blot anti-MPX under reducing and non-reducing conditions (freshly prepared DTT and/or phosphine, 1&#xa0;mM).</p>
</sec>
<sec id="s4_13">
<title>Macrophage Culture and Infection</title>
<p>The murine macrophage cell line J774A.1 [American Type Culture Collection (ATCC-TIB-67)] was cultured in DMEM (Sigma) supplemented with L-glutamine (2&#xa0;mM), penicillin (100&#xa0;units/ml), streptomycin (100&#xa0;mg/ml), and 10% heat-inactivated fetal bovine serum at 37&#xb0;C in a 5% CO<sub>2</sub> atmosphere.</p>
<p>Metacyclic trypomastigotes obtained as described above were used to infect confluent Vero cells (American Type Culture Collection) at 37&#xb0;C in a 5% CO<sub>2</sub> atmosphere. Culture-derived trypomastigotes were used to infect macrophages seeded in Lab-Tek tissue culture chamber with or without stimulation with IFN-&#x3b3; (100&#xa0;U/ml) and LPS (5&#xa0;&#xb5;g/ml) in a parasite:cell ratio of 3:1 (<xref ref-type="bibr" rid="B1">Alvarez et&#xa0;al., 2011</xref>). After 2&#xa0;h, no engulfed parasites were removed by washing twice in PBS (pH 7.4) and cells were further incubated for 24&#xa0;h in DMEM at 37&#xb0;C. The infected cells were fixed in fresh formaldehyde solution [4% (v/v) in PBS] for 10&#xa0;min at room temperature, washed with PBS, and permeabilized for 5&#xa0;min with Triton X-100 (0.1%, v/v) in PBS. The number of parasites per macrophage was determined by DAPI staining (5&#xa0;mg/ml). Preparations were analyzed using a fluorescence microscope (Nikon Eclipse TE-200) at a magnification of &#xd7;100, and digital photographs of infected cells were recorded. At least 1,000 cells from three independent experiments were counted. Results are expressed as the number of amastigotes per 100 cells (% of infection) relative to the control and represent the mean of three independent experiments. For some experiments, the culture-derived trypomastigotes were preincubated with CA as described above.</p>
</sec>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author Contributions</title>
<p>GS: cell culture, infection experiments, enzyme activities, flow cytometry and HPLC experiments, data collection, analysis, interpretation, and writing of the article. DE: flow cytometry and HPLC experiments. RR: data interpretation and critical revision of the article. LP: conception and design of the work, data interpretation, and writing of the article. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>GS and DE were funded by fellowships from the Comisi&#xf3;n Acad&#xe9;mica de Posgrado, Universidad de la Rep&#xfa;blica and Agencia Nacional de Investigaci&#xf3;n e Innovaci&#xf3;n, respectively. This work was supported by grants from Universidad de la Rep&#xfa;blica: Espacio Interdisciplinario (to RR), Comisi&#xf3;n Sectorial de Investigaci&#xf3;n Cient&#xed;fica, I+D-2017 (to LP and GS), I+D-2020 (to LP, DE and GS), and Grupos 2018 (to RR). Additional support was obtained from Programa de Desarrollo de Ciencias B&#xe1;sicas (PEDECIBA, Uruguay) and the Uruguayan National System of Researchers (SNI) from ANII.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="s10" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2022.749476/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2022.749476/full#supplementary-material</ext-link>
</p>
  <supplementary-material xlink:href="Presentation_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarez</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Intraphagosomal Peroxynitrite as a Macrophage-Derived Cytotoxin Against Internalized Trypanosoma Cruzi: Consequences for Oxidative Killing and Role of Microbial Peroxiredoxins in Infectivity</article-title>. <source>J. Biol. Chem</source> <volume>286</volume>, <page-range>6627&#x2013;6640</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M110.167247</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boiani</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Boiani</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Cerecetto</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Mode of Action of Nifurtimox and N-Oxide-Containing Heterocycles Against Trypanosoma Cruzi: Is Oxidative Stress Involved</article-title>? <source>Biochem. Pharmacol</source> <volume>79</volume>, <page-range>1736&#x2013;1745</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2010.02.009</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonaldo</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Souto-Padron</surname> <given-names>T.</given-names>
</name>
<name>
<surname>De Souza</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Goldenberg</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Cell-Substrate Adhesion During Trypanosoma Cruzi Differentiation</article-title>. <source>J. Cell Biol.</source> <volume>106</volume>, <page-range>1349&#x2013;1358</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.106.4.1349</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brizuela</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Burgio</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Foote</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>McMorran</surname> <given-names>B. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Treatment of Erythrocytes With the 2-Cys Peroxiredoxin Inhibitor, Conoidin a, Prevents the Growth of Plasmodium Falciparum and Enhances Parasite Sensitivity to Chloroquine</article-title>. <source>PloS One</source> <volume>9</volume>, <elocation-id>e92411</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0092411</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Lindsay</surname> <given-names>J. G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Peroxiredoxin Family: An Unfolding Story</article-title>. <source>Sub-Cell Biochem.</source> <volume>83</volume>, <fpage>127</fpage>&#x2013;<lpage>147</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-319-46503-6_5</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castro</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Teixeira</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Romao</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Cruz</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Fl&#xf3;rido</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Leishmania Mitochondrial Peroxiredoxin Plays a Crucial Peroxidase-Unrelated Role During Infection: Insight Into Its Novel Chaperone Activity</article-title>. <source>PloS Pathog.</source> <volume>7</volume> (<issue>10</issue>), <elocation-id>e1002325</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1002325</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerecetto</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Antiparasitic Prodrug Nifurtimox: Revisiting its Activation Mechanism</article-title>. <source>Future Microbiol.</source> <volume>6</volume>, <page-range>847&#x2013;850</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/fmb.11.74</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Da Silva Manoel-Caetano</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>A. E.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Implications of Genetic Variability of Trypanosoma Cruzi for the Pathogenesis of Chagas Disease</article-title>. <source>Cadernos Saude Publica</source> <volume>23</volume>, <page-range>2263&#x2013;2274</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/S0102-311X2007001000002</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Souza</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>J. C. F.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Sterol Biosynthesis Pathway as Target for Anti-Trypanosomatid Drugs</article-title>. <source>Interdiscip. Perspect. Infect. Dis</source>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2009/642502</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Docampo</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Moreno</surname> <given-names>S. N.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Free Radical Metabolites in the Mode of Action of Chemotherapeutic Agents and Phagocytic Cells on Trypanosoma Cruzi</article-title>. <source>Rev. Infect. Dis.</source> <volume>6</volume>, <page-range>223&#x2013;238</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/clinids/6.2.223</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Docampo</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Stoppani</surname> <given-names>A. O. M.</given-names>
</name>
</person-group> (<year>1979</year>). <article-title>Generation of Superoxide Anion and Hydrogen Peroxide Induced by Nifurtimox in Trypanosoma Cruzi</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>197</volume>, <page-range>317&#x2013;321</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0003-9861(79)90251-0</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estrada</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Specker</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dias</surname> <given-names>P. P.</given-names>
</name>
<name>
<surname>Hissa</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>L. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Cardiomyocyte Diffusible Redox Mediators Control Trypanosoma Cruzi Infection: Role of Parasite Mitochondrial Iron Superoxide Dismutase</article-title>. <source>Biochem. J.</source> <volume>475</volume>, <page-range>1235&#x2013;1251</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BCJ20170698</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Folgueira</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Requena</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>A Postgenomic View of the Heat Shock Proteins in Kinetoplastids</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>31</volume>, <page-range>359&#x2013;377</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1574-6976.2007.00069.x</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goad</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Berens</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Marr</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Beach</surname> <given-names>D. H.</given-names>
</name>
<name>
<surname>Holz</surname> <given-names>G. G.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>The Activity of Ketoconazole and Other Azoles Against Trypanosoma Cruzi: Biochemistry and Chemotherapeutic Action <italic>In Vitro</italic>
</article-title>. <source>Mol. Biochem. Parasitol.</source> <volume>32</volume>, <page-range>179&#x2013;189</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0166-6851(89)90069-8</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffith</surname> <given-names>O. W.</given-names>
</name>
<name>
<surname>Meister</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>1979</year>). <article-title>Potent and Specific Inhibition of Glutathione Synthesis by Buthionine Sulfoximine (s-N-Butyl Homocysteine Sulfoximine)</article-title>. <source>J. Biol. Chem</source>. <volume>254</volume>, <page-range>7558&#x2013;75560</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0021-9258(18)35980-5</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname> <given-names>B. S.</given-names>
</name>
<name>
<surname>Bot</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume>, <page-range>13088&#x2013;13095</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.230847</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname> <given-names>B. S.</given-names>
</name>
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <page-range>115&#x2013;123</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.05135-11</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xfc;bel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Krobitsch</surname> <given-names>S.</given-names>
</name>
<name>
<surname>H&#xf6;rauf</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Clos</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Leishmania Major Hsp100 Is Required Chiefly in the Mammalian Stage of the Parasite</article-title>. <source>Mol. Cell. Biol</source> <volume>17</volume>, <page-range>5987&#x2013;5995</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mcb.17.10.5987</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hugo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Trujillo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Estrada</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Mastrogiovanni</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Linares</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Kinetics, Subcellular Localization, and Contribution to Parasite Virulence of a Trypanosoma Cruzi Hybrid Type a Heme Peroxidase (Tcapx-Ccp)</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>114</volume> (<issue>8</issue>), <fpage>E1326</fpage>&#x2013;<lpage>E1335</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1618611114</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isola</surname> <given-names>E. L. D.</given-names>
</name>
<name>
<surname>Lammel</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez Cappa</surname> <given-names>S. M.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Trypanosoma Cruzi: Differentiation After Interaction of Epimastigotes and Triatoma Infestans Intestinal Homogenate</article-title>. <source>Exp. Parasitol.</source> <volume>62</volume>, <page-range>329&#x2013;335</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0014-4894(86)90039-1</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xe4;&#xe4;ttel&#xe4;</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Heat Shock Proteins as Cellular Lifeguards</article-title>. <source>Ann. Med.</source> <volume>31</volume>, <page-range>261&#x2013;271</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/07853899908995889</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname> <given-names>H. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>Y. M.</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>J. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Phosphorylation and Concomitant Structural Changes in Human 2-Cys Peroxiredoxin Isotype I Differentially Regulate its Peroxidase and Molecular Chaperone Functions</article-title>. <source>FEBS Lett.</source> <volume>580</volume>, <page-range>351&#x2013;355</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.febslet.2005.12.030</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname> <given-names>H. H.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>K. O.</given-names>
</name>
<name>
<surname>Chi</surname> <given-names>Y. H.</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>B. G.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>J. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Two Enzymes in One: Two Yeast Peroxiredoxins Display Oxidative Stress-Dependent Switching From a Peroxidase to a Molecular Chaperone Function</article-title>. <source>Cell</source> <volume>117</volume> (<issue>5</issue>), <fpage>625</fpage>&#x2013;<lpage>635</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2004.05.002</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>Y. E.</given-names>
</name>
<name>
<surname>Hipp</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Bracher</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hayer-Hartl</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ulrich Hartl</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Molecular Chaperone Functions in Protein Folding and Proteostasis</article-title>. <source>Annu. Rev. Biochem.</source> <volume>82</volume>, <page-range>323&#x2013;355</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-biochem-060208-092442</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krauth-Siegel</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Jacoby</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Schirmer</surname> <given-names>R. H.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Trypanothione and N1-Glutathionylspermidine: Isolation and Determination</article-title>. <source>Methods Enzymol</source> <volume>251</volume> (<issue>1975</issue>), <fpage>287</fpage>&#x2013;<lpage>294</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0076-6879(95)51131-8</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurent</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Barnabe</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Quesney</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Noel</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tibayrenc</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Impact of Clonal Evolution on the Biological Diversity of Trypanosoma Cruzi</article-title>. <source>Parasitology</source> <volume>114</volume>, <page-range>213&#x2013;218</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/S0031182096008414</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Botting</surname> <given-names>C. H.</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Walton</surname> <given-names>J. A. G.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Slawin</surname> <given-names>A. M. Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Optimisation of Conoidin a, a Peroxiredoxin Inhibitor</article-title>. <source>Chem. Med. Chem.</source> <volume>5</volume>, <page-range>41&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cmdc.200900391</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mares</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Mel&#xe9;ndez-L&#xf3;pez</surname> <given-names>S. G.</given-names>
</name>
<name>
<surname>Ramos</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Acid-Denatured Green Fluorescent Protein (GFP) as Model Substrate to Study the Chaperone Activity of Protein Disulfide Isomerase</article-title>. <source>Int. J. Mol. Sci</source> <volume>12</volume>, <page-range>4625&#x2013;4636</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms12074625</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Petruk</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Hugo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pi&#xf1;eyro</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Demicheli</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Structural and Molecular Basis of the Peroxynitrite-Mediated Nitration and Inactivation of Trypanosoma Cruzi Iron-Superoxide Dismutases (Fe-Sods) a and B</article-title>. <source>J. Biol. Chem</source> <volume>289</volume>, <page-range>12760&#x2013;12778</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.m113.545590</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed;nez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Prolo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Estrada</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Rios</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Pi&#xf1;eyro</surname> <given-names>M. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Cytosolic Fe-Superoxide Dismutase Safeguards Trypanosoma Cruzi From Macrophage-Derived Superoxide Radical</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>116</volume>, <page-range>8879&#x2013;8888</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1821487116</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mateo</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Mar&#xed;n</surname> <given-names>C.</given-names>
</name>
<name>
<surname>P&#xe9;rez-Cord&#xf3;n</surname> <given-names>G.</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Moreno</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Purification and Biochemical Characterization of Four Iron Superoxide Dismutases in Trypanosoma Cruzi</article-title>. <source>Memorias Do Inst Oswaldo Cruz</source> <volume>103</volume>, <page-range>271&#x2013;276</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/S0074-02762008000300008</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maya</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Repetto</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Agos&#xed;n</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ojeda</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Tellez</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Gaule</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>1997</year>). <article-title>Effects of Nifurtimox and Benznidazole Upon Glutathione and Trypanothione Content in Epimastigote, Trypomastigote and Amastigote Forms of Trypanosoma Cruzi</article-title>. <source>Mol. Biochem. Parasitol.</source> <volume>86</volume>, <page-range>101&#x2013;106</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0166-6851(96)02837-X</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCabe</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Remington</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Araujo</surname> <given-names>F. G.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Ketoconazole Inhibition of Intracellular Multiplication of Trypanosoma Cruzi and Protection of Mice Against Lethal Infection With the Organism</article-title>. <source>J. Infect. Dis.</source> <volume>150</volume>, <page-range>594&#x2013;601</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/150.4.594</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCall</surname> <given-names>L. I.</given-names>
</name>
<name>
<surname>McKerrow</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Determinants of Disease Phenotype in Trypanosomatid Parasites</article-title>. <source>Trends Parasitol.</source> <volume>30</volume>, <page-range>342&#x2013;349</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pt.2014.05.001</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCord</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Fridovich</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>1969</year>). <article-title>Superoxide Dismutase. An Enzymic Function for Erythrocuprein (Hemocuprein)</article-title>. <source>J. Biol. Chem.</source> <volume>244</volume>, <page-range>6049&#x2013;6055</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(18)63504-5</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meister</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Glutathione Biosynthesis and its Inhibition</article-title>. <source>Methods Enzymol.</source> <volume>252</volume>, <page-range>26&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0076-6879(95)52005-8</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morais</surname> <given-names>M. A. B.</given-names>
</name>
<name>
<surname>Giuseppe</surname> <given-names>P. O.</given-names>
</name>
<name>
<surname>Souza</surname> <given-names>T. A. C. B.</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Honorato</surname> <given-names>R. V.</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>P. S. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Calcium and Magnesium Ions Modulate the Oligomeric State and Function of Mitochondrial 2-Cys Peroxiredoxins in Leishmania Parasites</article-title>. <source>J. Biol. Chem</source> <volume>292</volume>, <page-range>7023&#x2013;7039</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M116.762039</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murta</surname> <given-names>S. M. F.</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>R. T.</given-names>
</name>
<name>
<surname>Brener</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Romanha</surname> <given-names>A. J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Molecular Characterization of Susceptible and Naturally Resistant Strains of Trypanosoma Cruzi to Benznidazole and Nifurtimox</article-title>. <source>Mol. Biochem. Parasitol</source> <volume>93</volume>, <page-range>203&#x2013;214</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0166-6851(98)00037-1</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Pool</surname> <given-names>C. D.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>C. Y. B.</given-names>
</name>
<name>
<surname>Treger</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Cappello</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Peroxiredoxin-1 From the Human Hookworm Ancylostoma Ceylanicum Forms a Stable Oxidized Decamer and is Covalently Inhibited by Conoidin a</article-title>. <source>Chem. Biol</source> <volume>20</volume>, <page-range>991&#x2013;1001</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chembiol.2013.06.011</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez-Molina</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Molina</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Chagas Disease</article-title>. <source>Lancet</source> <volume>391</volume>, <page-range>82&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(17)31612-4</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez-Morales</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lanz-Mendoza</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hurtado</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Espinosa</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Espinoza</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Proteomic Analysis of Trypanosoma Cruzi Epimastigotes Subjected to Heat Shock</article-title>. <source>J. Biomed. Biotechnol.</source> <volume>2012</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2012/902803</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nelson</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Parsonage</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Poole</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Karplus</surname> <given-names>P. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Peroxiredoxins: Guardians Against Oxidative Stress and Modulators of Peroxide Signaling</article-title>. <source>Trends Biochem. Sci.</source> <volume>40</volume>, <page-range>435&#x2013;445</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibs.2015.05.001</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2009</year>a). <article-title>Fighting the Oxidative Assault: The Trypanosoma Cruzi Journey to Infection</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>12</volume>, <page-range>415&#x2013;421</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mib.2009.06.011</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Irigo&#xed;n</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Mitochondrial Superoxide Radicals Mediate Programmed Cell Death in Trypanosoma Cruzi: Cytoprotective Action of Mitochondrial Iron Superoxide Dismutase Overexpression</article-title>. <source>Biochem. J.</source> <volume>403</volume>, <fpage>323</fpage>&#x2013;<lpage>334</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20061281</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Peroxiredoxins Play a Major Role in Protecting Trypanosoma Cruzi Against Macrophage- and Endogenously-Derived Peroxynitrite</article-title>. <source>Biochem. J.</source> <volume>410</volume>, <page-range>359&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20071138</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Trypanosoma Cruzi Antioxidant Enzymes as Virulence Factors in Chagas Disease</article-title>. <source>Antioxid Redox Signal</source>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/ars.2012.4618</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>L-Arginine-Dependent Suppression of Apoptosis in Trypanosoma Cruzi: Contribution of the Nitric Oxide and Polyamine Pathways</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>98</volume>, <page-range>7301&#x2013;7306</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.121520398</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Trujillo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Reactive Species and Pathogen Antioxidant Networks During Phagocytosis</article-title>. <source>J. Exp. Med.</source> <volume>216</volume>, <page-range>501&#x2013;516</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20181886</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacenza</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zago</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Basombrio</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2009</year>b). <article-title>Enzymes of the Antioxidant Network as Novel Determiners of Trypanosoma Cruzi Virulence</article-title>. <source>Int. J. Parasitol.</source> <volume>39</volume>, <page-range>1455&#x2013;1464</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijpara.2009.05.010</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pi&#xf1;eyro</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Arcari</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Robello</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Trujillo</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Tryparedoxin Peroxidases From Trypanosoma Cruzi: High Efficiency in the Catalytic Elimination of Hydrogen Peroxide and Peroxynitrite</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>507</volume>, <page-range>287&#x2013;295</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.abb.2010.12.014</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pi&#xf1;eyro</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Arias</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ricciardi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Robello</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Parodi-Talice</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Oligomerization Dynamics and Functionality of Trypanosoma Cruzi Cytosolic Tryparedoxin Peroxidase as Peroxidase and Molecular Chaperone</article-title>. <source>Biochim. Biophys. Acta - Gen. Subj.</source> <volume>1863</volume> (<issue>10</issue>), <fpage>1583</fpage>&#x2013;<lpage>1594</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbagen.2019.06.013</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pi&#xf1;eyro</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Parodi-Talice</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Arcari</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Robello</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Peroxiredoxins From Trypanosoma Cruzi: Virulence Factors and Drug Targets for Treatment of Chagas Disease</article-title>? <source>Gene</source> <volume>408</volume>, <page-range>45&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.gene.2007.10.014</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pi&#xf1;eyro</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Pizarro</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Lema</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Pritsch</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Cayota</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bentley</surname> <given-names>G. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Crystal Structure of the Tryparedoxin Peroxidase From the Human Parasite Trypanosoma Cruzi</article-title>. <source>J. Struct. Biol.</source> <volume>150</volume>, <page-range>11&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jsb.2004.12.005</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prathalingham Radhika</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Horn</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Deletion of the Trypanosoma Brucei Superoxide Dismutase Gene Sodb1 Increases Sensitivity to Nifurtimox and Benznidazole</article-title>. <source>Antimicrob Agents Chemother.</source> <volume>51</volume>, <page-range>755&#x2013;758</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.01360-06</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Peluffo</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Naviliat</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Cayota</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Unraveling Peroxynitrite Formation in Biological Systems</article-title>. <source>Free Radical Biol. Med</source> <volume>30</volume>, <page-range>463&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0891-5849(00)00373-7</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rassi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rassi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Marin-Neto</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Chagas Disease</article-title>. <source>Lancet</source> <volume>375</volume>, <page-range>1388&#x2013;1402</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(10)60061-X</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhee</surname> <given-names>S. G.</given-names>
</name>
<name>
<surname>Woo</surname> <given-names>H. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Multiple Functions of Peroxiredoxins: Peroxidases, Sensors and Regulators of the Intracellular Messenger H2O2, and Protein Chaperones</article-title>. <source>Antioxid. Redox Signaling</source> <volume>5</volume>, <page-range>781&#x2013;794</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/ars.2010.3393</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhee</surname> <given-names>S. G.</given-names>
</name>
<name>
<surname>Woo</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>Kil</surname> <given-names>I. S.</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>S. H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Peroxiredoxin Functions as a Peroxidase and a Regulator and Sensor of Local Peroxides</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume>, <page-range>4403&#x2013;4410</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.R111.283432</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saccoccia</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Micco</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Boumis</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Brunori</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Koutris</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Miele</surname> <given-names>A. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Moonlighting by Different Stressors: Crystal Structure of the Chaperone Species of a 2-Cys Peroxiredoxin</article-title>. <source>Structure</source> <volume>20</volume>, <page-range>429&#x2013;439</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.str.2012.01.004</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lindquist</surname> <given-names>S. L.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>HSP104 Required for Induced Thermotolerance</article-title>. <source>Science</source> <volume>48</volume>, <page-range>1112&#x2013;1115</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.2188365</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shonhai</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Maier</surname> <given-names>A. G.</given-names>
</name>
<name>
<surname>Przyborski</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Blatch</surname> <given-names>G. L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Intracellular Protozoan Parasites of Humans: The Role of Molecular Chaperones in Development and Pathogenesis</article-title>. <source>Protein Pept. Lett.</source> <volume>18</volume> (<issue>2</issue>), <fpage>143</fpage>&#x2013;<lpage>575</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/092986611794475002</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobotta</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Liou</surname> <given-names>W.</given-names>
</name>
<name>
<surname>St&#xf6;cker</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Talwar</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Oehler</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ruppert</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Peroxiredoxin-2 and STAT3 Form a Redox Relay for H2O2 Signaling</article-title>. <source>Nat. Chem. Biol</source> <volume>11</volume>, <page-range>64&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nchembio.1695</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Cruz</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Tse</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Koldewey</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Southworth</surname> <given-names>D. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Mitochondrial Peroxiredoxin Functions as Crucial Chaperone Reservoir in Leishmania Infantum</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>112</volume> (<issue>7</issue>), <fpage>E616</fpage>&#x2013;<lpage>E245</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1419682112</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Tse</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Makepeace</surname> <given-names>K. A. T.</given-names>
</name>
<name>
<surname>Meinen</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Borchers</surname> <given-names>C. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Chaperone Activation and Client Binding of a 2-Cysteine Peroxiredoxin</article-title>. <source>Nat. Commun.</source> <volume>10</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-08565-8</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomson</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Denicola</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Radi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>The Trypanothione-Thiol System in Trypanosoma Cruzi as a Key Antioxidant Mechanism Against Peroxynitrite-Mediated Cytotoxicity</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>412</volume> (<issue>1</issue>), <fpage>55</fpage>&#x2013;<lpage>645</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0003-9861(02)00745-2</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trochine</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Creek</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Faral-Tello</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Barrett</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Robello</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Benznidazole Biotransformation and Multiple Targets in Trypanosoma Cruzi Revealed by Metabolomics</article-title>. <source>PloS Negl Trop. Dis</source>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0002844</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trujillo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Budde</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Pi&#xf1;eyro</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Stehr</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Robello</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Floh&#xe9;</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Trypanosoma Brucei and Trypanosoma Cruzi Tryparedoxin Peroxidases Catalytically Detoxify Peroxynitrite <italic>via</italic> Oxidation of Fast Reacting Thiols</article-title>. <source>J. Biol. Chem.</source> <volume>279</volume>, <page-range>34175&#x2013;34182</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M404317200</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urbina</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Vivas</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Visbal</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Contreras</surname> <given-names>L. M.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Modification of the Sterol Composition of Trypanosoma (Schizotrypanum) Cruzi Epimastigotes by &#x394;24(25)-Sterol Methyl Transferase Inhibitors and Their Combinations With Ketoconazole</article-title>. <source>Mol. Biochem. Parasitol.</source> <volume>73</volume>, <page-range>199&#x2013;210</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0166-6851(95)00117-J</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Bromley</surname> <given-names>E. V.</given-names>
</name>
<name>
<surname>Miles</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2002</year>a). <article-title>The Trypanosoma Cruzi Enzyme Tcgpxi is a Glycosomal Peroxidase and can be Linked to Trypanothione Reduction by Glutathione or Tryparedoxin</article-title>. <source>J. Biol. Chem.</source> <volume>277</volume>, <page-range>17067&#x2013;17071</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111126200</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Obado</surname> <given-names>S. O.</given-names>
</name>
<name>
<surname>Mauricio</surname> <given-names>I. L.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2002</year>b). <article-title>Trypanosoma Cruzi Expresses a Plant-Like Ascorbate-Dependent Hemoperoxidase Localized to the Endoplasmic Reticulum</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>99</volume> (<issue>21</issue>), <fpage>13453</fpage>&#x2013;<lpage>13585</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.202422899</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Horn</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Cheeseman</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>A Mechanism for Cross-Resistance to Nifurtimox and Benznidazole in Trypanosomes</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>99</volume>, <page-range>13453&#x2013;13458</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0711014105</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Touitha</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mauricio</surname> <given-names>I. L.</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2002</year>c). <article-title>Tcgpxii, a Glutathione-Dependent Trypanosoma Cruzi Peroxidase With Substrate Specificity Restricted to Fatty Acid and Phospholipid Hydroperoxides, Is Localized to the Endoplasmic Reticulum</article-title>. <source>Biochem. J.</source> <volume>364</volume>, <page-range>787&#x2013;794</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20020038</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Temperton</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Mondragon</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Distinct Mitochondrial and Cytosolic Enzymes Mediate Trypanothione- Dependent Peroxide Metabolism in Trypanosoma Cruzi</article-title>. <source>J. Biol. Chem.</source> <volume>275</volume>, <page-range>8220&#x2013;8225</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.275.11.8220</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wood</surname> <given-names>Z. A.</given-names>
</name>
<name>
<surname>Poole</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Hantgan</surname> <given-names>R. R.</given-names>
</name>
<name>
<surname>Andrew Karplus</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Dimers to Doughnuts: Redox-Sensitive Oligomerization of 2-Cysteine Peroxiredoxins</article-title>. <source>Biochemistry</source> <volume>41</volume>, <page-range>5493&#x2013;5504</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi012173m</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wood</surname> <given-names>Z. A.</given-names>
</name>
<name>
<surname>Schr&#xf6;der</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Robin Harris</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Poole</surname> <given-names>L. B.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Structure, Mechanism and Regulation of Peroxiredoxins</article-title>. <source>Trends Biochem. Sci.</source> <volume>28</volume>, <page-range>32&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0968-0004(02)00003-8</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yewdall</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Venugopal</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Desfosses</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Abrishami</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Yosaatmadja</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hampton</surname> <given-names>M. B. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Structures of Human Peroxiredoxin 3 Suggest Self-Chaperoning Assembly That Maintains Catalytic State</article-title>. <source>Structure</source> <volume>24</volume> (<issue>7</issue>), <fpage>1120</fpage>&#x2013;<lpage>1295</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.str.2016.04.013</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>